Parathyroid hormone
FDA-approved rhPTH(1-84) for hypoparathyroidism (Natpara) — check supply status.
What it's for
FDA-approved rhPTH(1-84) for hypoparathyroidism (Natpara) — check supply status.
What it's for
Recombinant human parathyroid hormone 1–84 replaces missing PTH (parathyroid hormone, which manages calcium) in hypoparathyroidism. Adjunct to calcium and vitamin D to control hypocalcemia in hypoparathyroidism.
What it does for the body
Adjunct to calcium and vitamin D to control hypocalcemia in hypoparathyroidism. U.S. supply has faced recalls/restrictions historically — verify current availability. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
PTH1 receptors (lock-and-key landing spots on cells) effects on bone and kidney regulate calcium-phosphate balance. Researchers map these ideas in cells and animals first; human proof has to clear a higher bar.
Research context
Bottom line for readers: Parathyroid hormone has a defined FDA-approved story. Use the citations tab to open labels and trial registries, and treat anything beyond the label as unverified.
Studied for (literature interest)
- Bones research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Parathyroid hormone — FDA.gov search
- ClinicalTrials.gov search: Parathyroid hormone — U.S. clinical trials registry
- Drugs@FDA search: Parathyroid hormone — FDA drug database (if approved)
- PubMed search: Parathyroid hormone — NCBI PubMed
- PubMed Central search: Parathyroid hormone — NCBI PMC